Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis and Gates Foundation join forces on sickle cell disease research

February 17, 2021
Research and Development Novartis, sickle cell disease

Novartis has entered into a grant agreement with the Bill & Melinda Gates Foundation, under which the foundation will fund …

News

FDA approves Novartis’ heart failure drug Entresto

February 17, 2021
Research and Development FDA, Novartis

The FDA has approved Novartis’ Entresto (sacubitril/valsartan) to reduce the risk of cardiovascular death and hospitalisation for heart failure in …

News

North Korea accused of attempted Pfizer hack to steal COVID-19 vaccine data

February 16, 2021
Manufacturing and Production COVID, COVID Vaccine, COVID-19, North Korea, Pfizer, Pfizer vaccine, Vaccine

North Korea has tried to hack into Pfizer’s servers in order to ascertain its COVID-19 vaccine technology, according to a …

News

South Korea orders 46 million more Novavax and Pfizer COVID-19 vaccines

February 16, 2021
Manufacturing and Production COVID, COVID-19, Novavax, Pfizer, Vaccine, south korea

South Korea has arranged deals with Novavax and Pfizer-BioNTech to buy enough COVID-19 vaccines for 23 million more people.

News
who_flag

WHO approves two versions of AstraZeneca’s COVID-19 vaccine

February 16, 2021
Manufacturing and Production AstraZeneca, COVID-19, WHO

The WHO has greenlighted two versions of the Oxford-AstraZeneca COVID-19 vaccine for emergency use, granting them authorisation to be rolled …

News
enhertu

Daiichi Sankyo and AstraZeneca’s breast cancer drug Enhertu approved in UK

February 16, 2021
Manufacturing and Production AstraZeneca, Cancer, Daiichi Sankyo

Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has been granted conditional authorisation in the UK as a monotherapy for the …

News
image_readtop_2018_569751_15365546683454581

Celltrion’s inflammatory disease drug Yuflyma gets EU approval for 13 indications

February 16, 2021
Manufacturing and Production EC, celltrion

The European Commission (EC) has granted marketing authorisation for Celltrion’s Yuflyma, an adalimumab biosimilar, across all thirteen intended indications for …

News
Eli Lilly front sign

University of Glasgow and Lilly sign £4.6m immunological disease partnership

February 15, 2021
Sales and Marketing Eli Lilly, University of Glasgow, arthritis, fibrosis, lilly, uofg

The University of Glasgow and Eli Lilly and Company have entered into a research collaboration, across four diseases, worth £4.6 …

News

Pfizer COVID-19 vaccine proven 94% effective in biggest study yet

February 15, 2021
Sales and Marketing COVID-19, Pfizer, Pfizer vaccine, Vaccine, coronavirus

The Pfizer-BioNTech COVID-19 vaccine has been proven to be 94% effective, according to the first major study to evaluate the …

News
astrazeneca_sign_sky

AstraZeneca’s COVID-19 vaccine to be trialled in children

February 15, 2021
Sales and Marketing AstraZeneca, COVID-19

The Oxford-AstraZeneca COVID-19 vaccine is to be tested on children in the UK in a new trial commencing this month. …

News

Genentech’s injectable eye medicine extends time between treatments for two conditions

February 15, 2021
Sales and Marketing Genentech

Genentech has announced detailed, positive results from four Phase III studies of its investigational bispecific antibody, faricimab, for the treatment …

News

Molecular Templates signs cancer deal with BMS worth up to $1.3bn

February 15, 2021
Sales and Marketing Bristol-Myers Squibb, bristol myers squibb

Molecular Templates and Bristol Myers Squibb have entered into a worldwide strategic research collaboration worth up to $1.3 billion, to …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

February 12, 2021
Medical Communications

Over the past week, AstraZeneca’s COVID-19 jab has been at the centre of disputes about vaccine efficiency both in older …

News
opdivo_1_1

NICE recommends Bristol Myers Squibb’s skin cancer drug Opdivo for NHS use

February 12, 2021
Medical Communications Bristol-Myers Squibb, NICE, bristol myers squibb

NICE has issued final draft guidance recommending the routine use of Bristol Myers Squibb (BMS)’s Opdivo (nivolumab) as an option …

News
who_flag

AstraZeneca COVID-19 vaccine still restricted, despite WHO assurances

February 12, 2021
Medical Communications AstraZeneca, COVID-19

Several European countries have continued to impose age restrictions on their rollouts of the Oxford University-AstraZeneca vaccine, despite WHO’s repeated …

News
ipos0_l

FDA approves Regeneron’s Evkeeza for HoFH

February 12, 2021
Medical Communications FDA, Regeneron

The FDA has approved Regeneron’s Evkeeza (evinacumab-dgnb) as an adjunct to other low-density lipoprotein cholesterol (LDL-C) lowering therapies to treat …

News

Arthritis drug tocilizumab cuts COVID-19 deaths in hospital trial

February 12, 2021
Medical Communications COVID-19

The rheumatoid arthritis drug tocilizumab can reduce the risk of death in severe COVID-19 patients and shorten the time spent …

News
gilead-sciences

Galapagos and Gilead halt Phase III trials for idiopathic pulmonary fibrosis drug

February 11, 2021
Gilead

Galapagos and Gilead have halted the ISABELA Phase III clinical studies for their autotaxin inhibitor ziritaxestat in patients with idiopathic …

News

NICE recommends treatments for pregnancy sickness in new draft guidance

February 11, 2021
NICE, Pregnant

NICE has recommended treatment options for severe pregnancy sickness for the first time, issuing recommendations in draft guidance published today.

News

Rentschler Biopharma to build new cell and gene therapy capabilities in the UK

February 11, 2021
Rentschler

The Cell and Gene Therapy Catapult (CGT Catapult) and Rentschler Biopharma have announced that Rentschler will establish their manufacturing capability …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025